Ameltolide
N/A
Report date: 2022/06/30 14:39:15
NME
Base Information
Drug NameAmeltolide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesResearch Corporation Technologies
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesResearch Corporation Technologies
Active IndicationsN/A
Inactive Indications